A Study to Assess the Hematopoyetic Response of Anemic Patients With Hematologic Malignancies Treated With Erythropoietin B
NCT02608060
·
clinicaltrials.gov ↗
PHASE4
Phase
TERMINATED
Status
4
Enrollment
INDUSTRY
Sponsor class
Stopped
Due to poor enrollment this study was terminated prematurely.
Conditions
Anemia
Interventions
DRUG:
Epoetin Beta
Sponsor
Hoffmann-La Roche